Please login to the form below

Not currently logged in
Email:
Password:

Ferring outlines US expansion plans

Swiss pharma company to develop corporate centre in New Jersey

Swiss pharma company Ferring Pharmaceuticals is increasing its US footprint with an expanded operations centre.

The new facility will house management, administration and support, commercial operations, manufacturing and product development.

Located in Parsippany, New Jersey the 25-acre site will also include a state-of-the-art manufacturing suite, next-generation product development laboratories, a fully equipped education and training conference centre, and administrative offices.

Aaron Graff, president and chief operating officer of Ferring Pharmaceuticals Inc, said: "As a private company, Ferring has a long term orientation, as well as a commitment to follow the science to benefit patients. This new facility underscores our long-term commitment to the US market, as well as the State of New Jersey.

"Together with our Global Research Center in San Diego, this symbolises our focus on accelerating Ferring growth in the United States.”

The Switzerland-based company's US subsidiary has experienced consistent double-digit growth and has approximately 600 employees.

22nd November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 women leaders in UK healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics